3Einhorn TA,Boskey AL,Gundberg CM,et al.The mineral and mechanical properties of bone in chronic experimental diabetes[J].Orthop Res,1998,6(3):317-320.
5Gopalakrishnan V,Vignesh RC,Arunakaran J,et al.Effects of glucose and its modulation by insulin and estradiol on BMSCdifferentiation into osteoblastic lineages[J].Biochem CellBiol,2006,84(1):93-101.
6Holl RW,Grabert M,Heinze E,et al.Age at onset and long-term metabolic control affect height in type 1 diabetes mellitus[J].Eur J Pediatr,1998,157:972-977.
3Leidig-Bruckner G, Ziegler R. Diabetes mellitus a risk for osteoporosis? Exp Clin Endocrinol Diabetes, 2001, 109 (Suppl 2):S493-514.
4Sosa M, Dominquez M, Navarro, et al. Bone mineral metabolisms normal in non-insulin-dependent diabetes mellitus. J Diabetes Complications, 1996,10: 201-205.
5Barrett-Conner E, Kritz-Silverstein D. Does Hyperinsulinemia preserve bone? Diabetes Care, 1996,19: 1388-1392.
6Kwon DJ, Kim JH, Chung KW, et al. Bone mineral density of the spine using dual energy x-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus. J Obstet Gynecol Res,1996,22:157-162.
7Meier CR, Schlienger RG, Kraezlin ME, et al. HMG-CoA reductase inhibitors and the risk of fractures. JAMA, 2000,283:3205-3210.
8Chung YS, Lee MD, Lee SK, et al. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. J Clin Endocrinol Metab, 2000,85:1137-1142.
9Kurland ES ,Rosen CJ ,Cosman F ,et al.Insulin-like growth factor-1 in men with idiopathic osteoporosis[J] .J Clin Endocrinol Metab,1997;82:2799-805.
10Jehle PM, Jehle DR , Mohan S ,et al .Serum levels of insulin-like growth factor system components and relationship to bone metabolism in typeⅠand typeⅡ diabetes mellitus patients[J]. J Endocrinol,1998;159:297-306.
5Xia J, Zhong Y, Huang G, et al. The relationship between insulin resistance and osteoporosis in elderly male type 2 diabetes mellitus and diabetic nephropathy[ J]. Ann Endocrinol (Paris) , 2012, 73(6) :5464-51.
6Leslie WD, Rubin MR, Schwartz AV, et al. Type 2 diabetes and bone[J]. JBoneMinerRes, 2012,27(11) :2231-7.
7Biver E. Use of bone turnover markers in clinical practice [ J]. Curr Opin Endocrinol Diabetes Obes, 2012, 19(6) : 468-473.
